Double-blind, randomized non-inferiority trial of a novel botulinum toxin A processed from the strain CBFC26, compared with onabotulinumtoxin A in the treatment of glabellar lines-Reference-Cited by-同舟云学术

Double-blind, randomized non-inferiority trial of a novel botulinum toxin A processed from the strain CBFC26, compared with onabotulinumtoxin A in the treatment of glabellar lines

Published:2014-03-05 Issue:12 Volume:28 Page:1761-1767
ISSN:0926-9959
Container-title:Journal of the European Academy of Dermatology and Venereology
language:en
Short-container-title:J Eur Acad Dermatol Venereol

Author:

Kim B.J.¹,Kwon H.H.²³,Park S.Y.²³,Min S.U.²³,Yoon J.Y.³,Park Y.M.⁴,Seo S.H.⁵,Ahn J.Y.⁶,Lee H.K.⁷,Suh D.H.²³

Affiliation:

1. Department of Dermatology; Chung-Ang University College of Medicine; Seoul Korea

2. Department of Dermatology; Seoul National University College of Medicine; Seoul Korea

3. Acne & Rosacea Research Laboratory; Seoul National University Hospital; Seoul Korea

4. Department of Dermatology; Seoul St Mary's Hospital; Catholic University of Korea; Seoul Korea

5. Department of Dermatology; Korea University College of Medicine; Seoul Korea

6. Department of Dermatology; National Medical Center; Seoul Korea

7. Department of Dermatology; College of Medicine; Eulji University; Seoul Korea

Funder

SNUH research fund

Publisher

Wiley

Subject

Infectious Diseases,Dermatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jdv.12408/fullpdf

Reference14 articles.

1. Botulinum toxin products overview;Carruthers;Skin Therapy Lett,2008

2. Botulinum A exotoxin use in clinical dermatology;Carruthers;J Am Acad Dermatol,1996

3. Advances in facial rejuvenation: botulinum toxin type a, hyaluronic acid dermal fillers, and combination therapies-consensus recommendations;Carruthers;Plast Reconstr Surg,2008

4. Treatment of glabellar frown lines with C. botulinum-A exotoxin;Carruthers;J Dermatol Surg Oncol,1992

5. A multicenter, double-blind, randomized, placebo-controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar lines;Carruthers;J Am Acad Dermatol,2002

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Phase-III Noninferiority, Randomized Controlled Trial of Letibotulinum Toxin A for the Improvement of Moderate-to-Severe Glabellar Wrinkles in China;Plastic and Reconstructive Surgery - Global Open;2024-01

2. Updates on Neuromodulators;Advances in Cosmetic Surgery;2023-12

3. Efficacy and Safety of Botulinum Toxin Type A for Treatment of Glabellar Lines: A Network Meta-Analysis of Randomized Controlled Trials;Aesthetic Plastic Surgery;2022-09-12

4. Botulax and the US development;Dermatological Reviews;2022-08

5. Evaluation of the safety and efficacy of a biosimilar abobotulinum toxin type A in treating moderate‐to‐severe glabellar lines: A non‐inferiority double blinded randomized controlled trial;Journal of Cosmetic Dermatology;2022-04-09